Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Triton acquires Bravida ASA
Mandate

Triton acquires Bravida ASA

February 19, 2007

Triton is acquiring roughly a total of 98 percent of the shares in Bravida ASA from Telenor ASA, Telenor Installation Holding AS, Sampo Life Insurance Company, Investment AB Latour, Stark II BV, Procuritas Capital Partners II LP, Procuritas Capital Partners IIB LP, SäkI AB and Baring European Fund (GP) LP. The Bravida group is the Nordic region's largest installation and service company with 8000 employees in Norway, Sweden and Denmark and sales of roughly SEK 9.5 billion. Bravida supplies solutions for the electricity, AC power, ventilation, security, service and property management industries, both the private and public sectors, and is represented in more that 150 locations in the Nordic region.

The legal advisor for Triton was the law firm of Vinge, with managing partner Christina Kokko handling mergers and acquisitions, and Mikael Ståhl for financing, who was assisted by Tom Zachrisson, Matti Scheffer, Peter Svanqvist, Johan Steen, Anna Elm and Kanja Berg.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026